pharma news today obesity drugs glp-1 october 2025 The World Health Organization just made a game-changing recommendation: medications are now recognized as part of long-term treatment for obesity—a milestone in treating as a chronic disease. “With prices starting glp-1 obesity drug news october

In cases of suspected cobalt hypersensitivity, an intradermal test dose should be administered

The standard retatrutide dosage chart provides the baseline, but researchers combining with tesamorelin would likely need to adjust based on individual response

A careful examination of the impact of G6PD-d on each of the key players in atherogenesis is overdue and likely on the horizon

For more information on tendons, see our BPC-157 guide + tendonitis preclinical research

The integration of these targeted therapy agents approved by the FDA into clinical practice is certainly a step ahead in precision medicine in the treatment of cancer [ Figure 5 ] , for it enables the stratification of therapies according to tumor biology and optimizes treatment outcomes for unique types of breast cancer

Recombinant Lys105 and Glu170 mutants were purified from E